2024-04-01T14:52:33-05:00 2023-05-31 571157523 APRIO LLP 111 ROCKVILLE PIKE SUITE 600 ROCKVILLE MD 20850 990 2022-06-01 237033369 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN AMER 3016648612 4500 EAST-WEST HIGHWAY 900 BETHESDA MD 20814 STEVEN RUBLOFF CHIEF EXECUTIVE OFFICER 3016648612 2024-03-25 1 STEVEN RUBLOFF 999009999 0 STACY CULLEN P00974308 3012316200 2024-03-25 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z ASHP FOUNDATION STEVEN RUBLOFF 4500 EAST-WEST HIGHWAY 900 BETHESDA MD 20814 14409655 0 X WWW.ASHPFOUNDATION.ORG X 1968 MD THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING (CONTINUED ON SCHEDULE O)THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE. 14 10 0 100 0 0 1421259 1414901 1380758 1439967 451714 423877 0 0 3253731 3278745 384147 526582 0 0 1650828 1717851 0 0 753099 712310 749234 2747285 2993667 506446 285078 13385213 12995656 941454 811149 12443759 12184507 X OUR MISSION: SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE. OUR VISION: AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME. 0 0 987225 194227 741425 EXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACY.ASHP STUDENT LEADERSHIP AWARD: THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. THE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM: THE 2022 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED BY SAMSON MEDICAL TECHNOLOGIES AND MEDI-DOSE. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPICS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. LITERATURE AWARDS PROGRAM: THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, RECOGNIZES TO STIMULATE INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED THROUGH VARIOUS ELECTRONIC PLATFORMS AND AT THE ASHP MIDYEAR CLINICAL MEETING. ASHP FOUNDATION PHARMACY STUDENT SCHOLARSHIP: IN FY23, THE ASHP FOUNDATION LAUNCHED A PHARMACY STUDENT SCHOLARSHIP. THE INAUGURAL PROGRAM, PART OF ASHP'S COMMITMENT TO INCREASING DIVERSITY, EQUITY, AND INCLUSION IN THE PHARMACY WORKFORCE, WAS SUPPORTED BY APEXUS. THE PROGRAM AWARDED A TOTAL OF $25,000 IN SCHOLARSHIPS TO P3 AND P4 PHARMACY STUDENTS ENROLLED AT US-ACCREDITED HISTORICALLY BLACK COLLEGES AND UNIVERSITIES (HBCUS) FOR THE 2023-2024 ACADEMIC YEAR. THE ASHP FOUNDATION PARTNERED WITH FIVE ACCREDITED HBCU SCHOOLS OF PHARMACY AND PROVIDED EACH WITH $5,000 IN FUNDING FOR DISBURSEMENT TO RECIPIENTS. EACH HBCU SCHOOLS OF PHARMACY WILL SELECT ONE RECIPIENT TO RECEIVE $5,000 OR TWO RECIPIENTS TO RECEIVE $2,500 EACH. THE RECIPIENTS WILL BE SELECTED BY THEIR RESPECTIVE SCHOOLS IN FALL 2023 AND WILL HAVE THE OPPORTUNITY TO PARTICIPATE IN ADDITIONAL ENGAGEMENT ACTIVITIES WITH ASHP IN FY24. PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM: SUPPORTED BY AN EDUCATIONAL GRANT FROM BAXTER AND OFFERED IN COLLABORATION WITH ASHP'S SECTION ON CLINICAL SPECIALISTS AND SCIENTISTS, THE PHARMACIST NUTRITION SUPPORT PATIENT-CARE IMPACT PROGRAM DISTANCE PROGRAM IS DESIGNED TO DEVELOP LEADERS WITH KNOWLEDGE AND SKILLS TO OPTIMIZE SAFE AND EFFECTIVE NUTRITIONAL SUPPORT NEEDS OF PATIENTS. THE PROGRAM SUPPORTS COHORTS OF UP TO TEN PHARMACY RESIDENTS IN PGY2 PROGRAMS. THE PROGRAM AND APPLICATION LAUNCHED IN FY23, WITH THE COHORT SELECTED IN FY24. MEDICATION SAFETY SCHOLARS: ASHP FOUNDATION IN PARTNERSHIP WITH EMILY JERRY FOUNDATION AND THE ASHP STUDENT FORUM SELECTED PARTICIPANTS FOR THE MEDICATION SAFETY SCHOLARS PROGRAM. THE PROGRAM IS A DISTANCE IMPACT PROGRAM STRUCTURED TO SUPPORT FIVE P2 AND P3 DOCTOR OF PHARMACY STUDENTS, PAIRED WITH ONE GROUP COACH, TO ENHANCE THEIR KNOWLEDGE AND SKILLS IN MEDICATION SAFETY. PROGRAM PARTICIPANTS MET IN JUNE 2022 AT THE ASHP SUMMER MEETINGS IN PHOENIX, ARIZONA TO SUPPORT A LIVE SESSION AT THE MEETING AND HAVE A NETWORKING DINNER TO CONCLUDE THE PROGRAM AND MEET WITH THE FACULTY IN PERSON. PHARMACY STUDENT CLINICAL SKILLS COMPETITION: ELLA DOMINGO & MARY ROTHENBERGER, PURDUE UNIVERSITY COLLEGE OF PHARMACY COMPETED FOR THE 2022 ASHP NATIONAL CLINICAL SKILLS COMPETITIONS AND WERE AWARDED IN DECEMBER 2022, DURING THE ASHP MIDYEAR CLINICAL MEETING IN LAS VEGAS, NV. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING 17 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN. VISITING LEADERS PROGRAM (VLP): THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. TEN LEADERS WERE INVOLVED IN 19 RESIDENCY VISITS, REACHING RESIDENTS, IN FY23. THERE WERE TWENTY VISITS SCHEDULED, BUT ONE WAS CANCELLED DUE TO LAST MINUTE CONFLICTS WITH LEADERS' SCHEDULES. OF THE TOTAL VISITS MAJORITY WERE CONDUCTED IN-PERSON.PHARMACY LEADERSHIP ACADEMY (PLA): THE PLA, SUPPORTED IN PART BY A GRANT FROM APEXUS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS AND PHARMACY TECHNICIANS. THE PLA CLASS IN FY23 CONSISTED OF 117 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2022 JUNE 2023. THE NUMBER OF GRADUATES FROM THIS CLASS BRINGS THE TOTAL NUMBER OF PLA GRADUATES TO 1,178 PHARMACISTS.WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY: THIS ANNUAL LUNCHEON-LECTURE EVENT, HOSTED BY ASHP IN PARTNERSHIP WITH THE ASHP FOUNDATION, IS DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER AND IS SUPPORTED BY DONORS TO THE ASHP FOUNDATION'S WILLIAM ZELLMER FUND. REAR ADMIRAL KRISTA M. PEDLEY, PHARMD, MS, DIRECTOR OF THE HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) OFFICE OF SPECIAL HEALTH INITIATIVES, AND THE LECTURE CEREMONY OCCURRED ON SEPTEMBER 13, 2022 DURING ASHP'S ANNUAL POLICY WEEK ACTIVITIES. NO EXPENSES WERE INCURRED BY THE ASHP FOUNDATION FOR THIS PROGRAM IN FY23. JOSEPH A. ODDIS ETHICS COLLOQUIUM: THE JOSEPH A. ODDIS ETHICS COLLOQUIUM FOCUSED ON THE TOPIC: ETHICS OF BIG DATA-I POLICY VALUES FOR IMPLEMENTING TODAY'S DATA TECHNOLOGY IN HEALTHCARE SYSTEMS. THE SESSION WAS PLANNED AND LED BY THE PROGRAM CHAIR IN JUNE DURING THE 2022 ASHP SUMMER MEETINGS & EXHIBITION IN PHOENIX, AZ. 826512 332355 0 INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.PHARMACY RESIDENCY EXPANSION GRANT: IN FY23, THE ASHP FOUNDATION, SUPPORTED BY AN EDUCATIONAL DONATION FROM MERCK, AWARDED $75,000 DOLLARS IN GRANTS TO PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. PHARMACY PRACTICE ADVANCEMENT DEMONSTRATION GRANT (PAI): THIS GRANT PREVIOUSLY AWARDED FUNDING UP TO $75,000 SPLIT INTO THREE (3) SEPARATE PAYMENTS FOR DEMONSTRATION PROJECTS RELATED TO ADVANCING PHARMACY PRACTICE AND IMPROVING OUTCOMES. THE GRANT PERIOD FOR THIS PROGRAM IS 24 MONTHS WITH THE POSSIBILITY FOR GRANTEES TO REQUEST AN EXTENSION UP TO ONE YEAR. A FINAL GRANT PAYMENT FOR ONE GRANTEE WAS REMITTED AFTER THE FINAL GRANT REPORT AND FINAL FINANCIAL REPORT WERE PROVIDED. THE AMOUNT REMITTED WAS LESS THAN BUDGETED AS IT REFLECTED THE "ACTUAL" PENDING AMOUNT THAT THE INSTITUTION PROVIDED IN THEIR FINAL FINANCIAL REPORT. ANOTHER GRANTEE REQUESTED A ONE-YEAR EXTENSION AND THE SCHEDULE FOR THE FINAL PAYMENT SHIFTED TO FY24. AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP: THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $10,000 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. RADIO FREQUENCY IDENTIFICATION (RFID) INITIATIVE: IN ALIGNMENT WITH THE ASHP INNOVATION CENTER AND THROUGH SUPPORT FROM FRESENIUS KABI, THE ASHP FOUNDATION CONTINUED TO WORK ON THE NEXT PHASES OF THE RFID INITIATIVE. IN FY23, THE ASHP FOUNDATION RELEASED TWO PODCASTS WITH EXPERTS DISCUSSING THE RESULTS OF PREVIOUS WORK AND THE POTENTIAL IMPACT OF RFID TECHNOLOGY ON PATIENT AND MEDICATION SAFETY. WORK ON THE RFID STRATEGIC ANALYSIS PROJECT IS EXPECTED TO BE COMPLETED IN FY24. PHARMACY LEADERSHIP SCHOLARS: WITH CORPORATE SUPPORT FROM CHIESI, THE SECOND CYCLE OF THE PHARMACY LEADERSHIP SCHOLARS PROGRAM WAS LAUNCHED. THE RESEARCH GRANT PROGRAM PROVIDES FUNDING FOR PROJECTS FOCUSED ON DEI, CONDUCTED BY EARLY-STAGE PHARMACISTS. IN ADDITION TO PROVIDING UP TO $10,000 IN GRANT FUNDING PER RECIPIENT, THE PROGRAM'S GOAL IS TO ENHANCE THE LEADERSHIP AND RESEARCH SKILLS OF RECIPIENTS AND TO PROVIDE A NETWORK OF PHARMACISTS POSITIONED TO LEAD FOR EQUITY. THE SELECTED PARTICIPANTS PARTICIPATED IN AN ONLINE IMPACT COLLABORATIVE CONSISTING OF FOUR EDUCATION MODULES WITH A FOCUS ON LEADERSHIP DEVELOPMENT AND DEI. FIVE PROPOSALS WERE RECEIVED AND ADVANCED FOR REVIEW BY AN EXTERNAL PANEL IN FY23 AND FOUR GRANTS WERE AWARDED IN FY23.COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS: CREATED IN PARTNERSHIP BY THE ASHP FOUNDATION AND THE AMERICAN NURSES FOUNDATION, THIS GRANT PROGRAM AIMS TO STIMULATE PATIENT-CENTERED INTERPROFESSIONAL HEALTH SERVICES RESEARCH THAT DEMONSTRATES MEANINGFUL OUTCOMES AND PROVIDES FUNDING OF $75,000. THE FIRST GRANTEE WAS SELECTED IN FY22 WITH FUNDING SPLIT INTO THREE PAYMENTS. THE SECOND GRANT PAYMENT WAS REMITTED IN FY23. THE SECOND CYCLE OF THE PROGRAM OPENED, TWENTY-FOUR PROPOSALS WERE RECEIVED AND ADVANCED FOR REVIEW BY AN EXTERNAL PANEL, AND ONE RESEARCH TEAM WAS AWARDED IN FY23. THE INITIAL GRANT PAYMENT FOR THE SECOND AWARDEE IS PENDING RECEIPT OF THEIR INTERNAL REVIEW BOARD (IRB) APPROVAL. BIOSIMILARS PROJECT: IN COLLABORATION WITH ASHP, THE FOUNDATION INITIATED A RESEARCH PROJECT TO EXPLORE THE OPPORTUNITIES AND BARRIERS RELATED TO IMPLEMENTING BIOSIMILARS IN PRACTICE. AMGEN SPONSORED THE PROJECT PROVIDING $126,800 TO THE FOUNDATION, OF WHICH $58,800 WAS BUDGETED FOR THE RESEARCH AND REPORT TO BE CONDUCTED BY THE FOUNDATION AND $68,000 WAS BUDGETED FOR THE DISSEMINATION ACTIVITIES TO BE DONE BY ASHP UNDER ITS ADVANTAGE BRAND. THE FOUNDATION CONVENED AN ADVISORY PANEL OF EXPERTS, INCLUDING PHARMACISTS, A PHYSICIAN AND PAYER REPRESENTATION AND ENGAGED AN INTERPROFESSIONAL RESEARCH PANEL IN VIRTUAL QUALITATIVE RESEARCH USING THE CANVAS SYSTEM. THE WORK OF THE VIRTUAL RESEARCH PANEL WAS COMPLETED IN FY22 AND THE ADVISORY PANEL BEGAN CREATING THE REPORT OF THE FINDINGS THAT WAS COMPLETED IN SUMMER, FY23. MUE PROJECT: DEVELOPMENT OF A MEDICATION-USE EVALUATION (MUE) TEMPLATE FOR ANDEXANET ALFA IN THE REVERSAL OF BLEEDING RELATED TO FACTOR XA INHIBITORS: THE FOUNDATION INITIATED A PROJECT TO CREATE AN MUE TEMPLATE FOR ANDEXANET. THE PROJECT WAS FUNDED BY ALEXION FOR $95,900. THE FOUNDATION ENGAGED A CONTRACTOR AND A MEDICAL WRITER AND THEN CONVENED CONTENT MATTER EXPERTS TO DEVELOP THE MUE TEMPLATE USING THE NEWLY PUBLISHED AJHP MUE GUIDELINES. THE DELIVERABLES OF THE PROJECT INCLUDED: A RESOURCE GUIDE THAT INCLUDES TEMPLATES WITH IMPLEMENTATION STRATEGIES, A WEBINAR, AND A MANUSCRIPT TO BE SUBMITTED TO AJHP FOR FIRST RIGHT OF REFUSAL. WORK ON THE DELIVERABLES WAS NOT COMPLETED IN FY22 AND CONTINUED INTO FY23, AS PLANNED. SPECIALTY PHARMACY GRANT: ADMINISTERED BY THE FOUNDATION, IN CLOSE CONSULTATION WITH THE ASHP SECTION OF SPECIALTY PHARMACY PRACTITIONERS, THE INAUGURAL RECIPIENTS FOR THE SPECIALTY PHARMACY: RHEUMATOID ARTHRITIS RESEARCH GRANT WERE AWARDED IN SPRING 2022. IN FY23, THE COHORT ENGAGED WITH FACULTY AND A COACH ON SEVERAL LIVE CALLS TO DISCUSS PRE-DETERMINED TOPICS RELATED TO RESEARCH, DISSEMINATING OUTCOMES, AND IMPLEMENTATION. THE COHORT WILL COMPLETE THEIR RESEARCH AND PRESENT IN THE NEXT FISCAL YEAR. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM: THIS GRANT PROGRAM IS FUNDED THROUGH THE ALMQUIST ENDOWMENT. NINETEEN SUBMISSIONS WERE RECEIVED FOR THE GRANT AND AN EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 7 GRANTS UP TO $5,000 EACH. NEW PRACTITIONER PHARMACIST LEADERSHIP DEVELOPMENT RESEARCH GRANT PROGRAM: FUNDED THROUGH THE MARIANNE F. IVEY LEADERSHIP DEVELOPMENT FUND, AWARDS NEW PRACTITIONER PHARMACISTS TO SUPPORT RESEARCH ON LEADERSHIP COMPETENCY DEVELOPMENT OR TO CREATE EDUCATION, RESOURCES AND TOOLS TO SUPPORT LEADERSHIP DEVELOPMENT. THE 2022-2023 APPLICATION CYCLE WAS NOT OPENED IN FY23. HOWEVER, THERE WAS TRACKING AND FOLLOW-UP OF PAST GRANTEES. OPTIMIZING TECHNOLOGY SOLUTIONS INNOVATION GRANT: FIVE APPLICATIONS WERE REVIEWED BY AN EXTERNAL PANEL IN ORDER TO DISTRIBUTE FUNDING TO GRANTEES IN FY23. CREATED IN PARTNERSHIP WITH THE ASHP INNOVATION CENTER AND SUPPORTED BY A GENEROUS DONATION FROM OMNICELL TO THE ASHP FOUNDATION, EACH GRANTEE WAS AWARDED UP TO $30,000. RESEARCH ADVISORY COUNCIL: IN FY23, ASHP FOUNDATION BOARD OF DIRECTORS REAPPOINTED FIVE MEMBERS TO THE RESEARCH ADVISORY COUNCIL (RAC) AND APPOINTED SEVEN NEW MEMBERS FOLLOWING AN OPEN CALL. THE RAC CONVENED VIRTUALLY THROUGHOUT THE YEAR TO UPDATE THE COUNCIL CHARTER, PLAN A RESEARCHER ROUNDTABLE, REVIEW THE LITERATURE AWARDS CATEGORIES AND CRITERIA, AND DISCUSS RESEARCH RESOURCES. THERE WERE TWO RESEARCH PODCASTS LAUNCHED IN FY23 AND THE RESEARCH ROUNDTABLE DURING THE ASHP MIDYEAR CLINICAL MEETING IN DECEMBER 2023 HAD APPROXIMATELY 30 PARTICIPANTS. NEW ACTIVITIES WERE ALSO PLANNED FOR FY24.PHARMACY FORECAST REPORT 2023: THE 2023 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2023 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 60,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2022 AND PREVIEWED DURING AN EDUCATIONAL SESSION AT THE 2022 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. 0 0 678542 THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS. 1813737 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 85 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 14 10 0 0 0 0 0 1 0 1 0 0 0 1 1 1 1 1 1 1 0 0 MD X TRACY YAKLYVICH 3016648696 4500 EAST-WEST HIGHWAY 900 BETHESDA MD 20814 CHRIS HATWIG DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 CHRISTENE JOLOWSKY TREASURER 1.00 4.00 X X 0 0 0 ELLEN WETTERLING DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 KELLY M SMITH CHAIR 1.00 0.00 X X 0 0 0 KEN PEREZ VICE CHAIR 1.00 0.00 X X 0 0 0 LINDA S TYLER IMMEDIATE PAST PRESIDENT OF ASHP 1.00 1.00 X 0 10500 0 LINDSEY THOMAS DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 PAUL C WALKER PRESIDENT OF ASHP 1.00 5.00 X 0 10000 0 PAUL W ABRAMOWITZ PRESIDENT 3.00 40.00 X X 0 1056203 62392 ROGER ANDERSON DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 SCOTT M SAMSON DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 STEVEN A RUBLOFF SECRETARY AND CEO 40.00 0.00 X X 375648 0 71543 THOMAS J RICE DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 WENDY HORTON DIRECTOR AT LARGE 1.00 0.00 X 0 0 0 BARBARA NUSSBAUM VP, RESEARCH AND EDUCATION 40.00 0.00 X 194806 0 62519 MARTHA CREWS VP, DEVELOPMENT 40.00 0.00 X 139571 0 48033 STEPHANIE BROWN DIRECTOR, OPERATIONS 40.00 0.00 X 129291 0 27155 839316 1076703 271642 4 0 1 0 0 358050 1056851 1414901 PHARMACY LEADERSHIP ACADEMY 611430 741425 741425 CORPORATE PARTNER PROGRAM 611430 678542 678542 SPONSORSHIPS 900099 20000 20000 1439967 436902 436902 11117885 11130910 -13025 -13025 -13025 3278745 1419967 0 443877 X 511482 511482 15100 15100 1048566 443212 198262 407092 546031 230799 103243 211989 10604 4482 2005 4117 29109 12304 5504 11301 83541 35311 15796 32434 10910 10910 49316 49316 435044 422175 364 12505 59225 48848 2923 7454 137455 45818 25430 66207 42206 42206 CREDIT CARD FEES 13078 13078 HONORARIA 2000 2000 2993667 1813737 426831 753099 506045 656263 547495 1390682 958430 74420 154944 62661 14946 294308 222832 99682 71476 10540167 10955064 115405 78230 48656 106303 13385213 12995656 177452 199420 764002 611729 941454 811149 X 3083557 3157407 9360202 9027100 12443759 12184507 13385213 12995656 285078 -544330 0 X X 0 1 X 1 0 X 1768602 928082 2768012 1421259 1414901 8300856 1768602 928082 2768012 1421259 1414901 8300856 3398472 4902384 406338 303024 338642 446440 436902 1931346 10232202 5099974 0.47910 0.42600 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 7284777 5804 -59928 140955 7089698 7675259 23200 -221586 192096 7284777 6731177 2650 2218348 1276916 7675259 6808429 1300 106680 185232 6731177 6838821 1480 93478 125350 6808429 0.07099 0.72236 0.20665 0 0 80945 80945 0 213363 141887 71476 71476 3238824 -544330 553725 9395 3229429 49316 49316 3278745 3498076 553725 553725 2944351 49316 49316 2993667 PART V, LINE 4: THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. 1 AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION 11325 RANDOM HILLS ROAD SUITE 360-A105 FAIRFAX VA 22030 530214882 501(C)3 10000 0 AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION FELLOWSHIP AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 4500 EAST-WEST HIGHWAY SUITE 900 BETHESDA MD 20814 520807628 501(C)6 194741 0 STUDENT LEADERSHIP AWARDS, PHARMACY STUDENT CLINICAL SKILLS COMPETITION, PHARMACY FORECAST REPORT, BIOSIMILARS PROJECT, SPECIALTY PHARMACY SURVEY, DIV PREVENTION ASSESSMENT TOOL GRANTS DANBURY HOSPITAL & NEW MILFORD HOSPITAL FOUNDATION 24 HOSPITAL AVENUE DANBURY CT 06810 237425557 501(C)3 10000 0 PHARMACY LEADERSHIP SCHOLARS GRANT LIMA MEMORIAL HOSPITAL 1001 BELLEFONTAINE AVENUE LIMA OH 45804 341883284 501(C)3 9000 0 PHARMACY RESIDENT PRACTIVE-BASED RESEARCH GRANT MAYO CLINIC HEALTH SYSTEM-SOUTHEAST MINNESOTA REGION 1000 FIRST DRIVE NW AUSTIN MN 55912 411404075 501(C)3 30000 0 OPTIMIZING TECHNOLOGY SOLUTIONS GRANT RHODE ISLAND HOSPITAL 167 POINT STREET BOX 42 CORO EAST - SUITE 1A PROVIDENCE RI 02903 050258954 501(C)3 26712 0 PHARMACY RESIDENCY EXPANSION AND PHARMACY RESIDENT PRATICE-BASED RESEARCH GRANT RIVERSIDE HEALTHCARE ASSOCIATION INC 608 DENBIGH BLVD STE 800 NEWPORT NEWS VA 23608 521241835 501(C)3 9806 0 PHARMACY LEADERSHIP SCHOLARS GRANT SENTARA HOSPITALS 6015 POPLAR HALL DR NORFOLK VA 23502 541547408 501(C)3 9999 0 PHARMACY LEADERSHIP SCHOLARS GRANT THE MCCLEAN HOSPITAL CORPORATION 115 MILL STREET BELMONT MA 02478 042697981 501(C)3 25000 0 PHARMACY RESIDENCY EXPANSION GRANT THE METHODIST HOSPITAL 6565 FANNIN STREET HOUSTON TX 77030 741180155 501(C)3 29003 0 RADIO FREQUENCY IDENTIFICATION INITIATIVE THE METHODIST HOSPITAL FOUNDATION 6565 FANNIN STREET SS2 HOUSTON TX 77030 760094743 501(C)3 25000 0 PHARMACY RESIDENCY EXPANSION GRANT THE RESEARCH FOUNDATION FOR SUNY 35 STATE STREET ALBANY NY 12207 141368361 501(C)3 9256 0 PHARMACY PRACTICE ADVANCEMENT DEMOSTRATION GRANT UNIVERSITY OF CINCINNATI 51 GOODMAN DRIVE CINCINNATI OH 45221 316000989 STATE UNIVERSITY 30000 0 OPTIMIZING TECHNOLOGY SOLUTIONS GRANT UNIVERSITY OF PITTSBURGH PO BOX 640458 PITTSBURGH PA 15264 250965591 501(C)3 30000 0 COLLABORATIVE CARE GRANT FOR NURSES AND PHARMACISTS 13 1 LITERATURE AWARDS 11 15100 PART I, LINE 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED, WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. X X X X X 0 0 0 0 0 1 1 1 0 PAUL W ABRAMOWITZ PRESIDENT 0 894671 0 133875 0 27657 0 29600 0 32792 0 1118595 0 0 STEVEN A RUBLOFF SECRETARY AND CEO 332055 0 23500 0 20093 0 29600 0 41943 0 447191 0 0 0 BARBARA NUSSBAUM VP, RESEARCH AND EDUCATION 184553 0 8419 0 1834 0 19897 0 42622 0 257325 0 0 0 MARTHA CREWS VP, DEVELOPMENT 132809 0 6090 0 672 0 14294 0 33739 0 187604 0 0 0 STEPHANIE BROWN DIRECTOR, OPERATIONS 123810 0 5261 0 220 0 12436 0 14719 0 156446 0 0 0 PART I, LINE 6 PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS. PART I, LINE 7 ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES. FORM 990, PART VI, SECTION A, LINE 7A THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. FORM 990, PART VI, SECTION A, LINE 8B THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY OFFICERS OF ASHP AND ASHP FOUNDATION AND BY THE BOARD BEFORE IT IS FILED. EACH MEMBER HAS THE OPPORTUNITY TO REVIEW THE FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING. FORM 990, PART VI, SECTION B, LINE 15A CHIEF EXECUTIVE OFFICER: PURSUANT TO THE BYLAWS, THE BOARD OF DIRECTORS HAS THE RESPONSIBILITY FOR THE SELECTION AND HIRING OF THE CEO OF THE ORGANIZATION. TEN MEMBERS OF THE BOARD ARE CONSIDERED INDEPENDENT PERSONS AND RECEIVE NO COMPENSATION FROM THE ORGANIZATION. THE BOARD REVIEWS SALARY SURVEY DATA REPORTS FOR OTHER COMPARABLE EXEMPT ORGANIZATIONS AS WELL AS DATA FOR POSITIONS WHICH HAVE SIMILAR RESPONSIBILITIES. OTHER EMPLOYEES WHO ARE EMPLOYED BY THE ORGANIZATION ARE "EMPLOYEES AT WILL". SALARIES FOR THESE INDIVIDUALS ARE DETERMINED USING RELEVANT COMPARABLE SALARY DATA. PRIOR TO FILLING A VACANT POSITION, A HIRING SUPERVISOR, IN CONJUNCTION WITH ASHP'S HUMAN RESOURCES DIVISION, RESEARCHES RELEVANT SALARY RANGES FOR THE POSITION. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 422,175. MANAGEMENT AND GENERAL EXPENSES 364. FUNDRAISING EXPENSES 12,505. TOTAL EXPENSES 435,044. FORM 990, PART XII, LINE 2C: THE OVERSIGHT PROCESS HAS NOT CHANGED FROM PRIOR YEARS. AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) 4500 EAST-WEST HIGHWAY SUITE 900 BETHESDA MD 20814 520807628 TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION MD 501(C)(6) N/A 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS P 1894251 RECORDED EXPENSES AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS S 1371445 CASH AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS N 522806 RECORDED EXPENSES AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS C 358050 CASH AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS O 455610 FAIR VALUE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS B 194741 CASH